Application of cationic liposome and polydeoxyribonucleosides composite using as medicament

Application of cationic liposome and polydeoxyribonucleosides composite using as medicament

  • CN 1,277,024 A
  • Filed: 06/11/1999
  • Published: 12/20/2000
  • Est. Priority Date: 06/11/1999
  • Status: Abandoned Application
First Claim
Patent Images

1. by cationic liposome and have 7,000-60,000 Dalton molecular weight, preferred 10,000-60, the complex that the polydeoxyribonucleotide of 000 Dalton molecular weight forms is made a kind of purposes of medicament, wherein said polydeoxyribonucleotide is by obtaining the nucleic acid depolymerization, and polydeoxyribonucleotide is positioned at the outer surface of liposome in complex.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×